Design Therapeutics (DSGN) Payables (2020 - 2021)
Historic Payables for Design Therapeutics (DSGN) over the last 2 years, with Q3 2021 value amounting to $3.3 million.
- Design Therapeutics' Payables changed N/A to $3.3 million in Q3 2021 from the same period last year, while for Sep 2021 it was $3.3 million, marking a year-over-year change of. This contributed to the annual value of $1.4 million for FY2020, which is N/A changed from last year.
- Latest data reveals that Design Therapeutics reported Payables of $3.3 million as of Q3 2021.
- Design Therapeutics' 5-year Payables high stood at $3.3 million for Q3 2021, and its period low was $1.4 million during Q4 2020.